Vox Markets Interview with Avacta CEO Alastair Smith
0
0
0 विचारों·
09/19/23
Following today’s “stunning” safety & efficacy data wrt Avacta's AVA6000 phase 1a clinical trial, I was delighted to catchup again with CEO Alastair Smith, who took me through the hugely significant news.
और दिखाओ
0 टिप्पणियाँ
sort इसके अनुसार क्रमबद्ध करें